`

European regulators approve once-daily Cialis

June 25, 2007

Eli Lilly and Co. won European approval today for its once-daily version of the impotence pill Cialis, Reuters reported.

The OK from the European Commission could help Lilly differentiate its erectile dysfunction therapy from competitor Viagra. Before, Cialis and Pfizer Inc.'s Viagra have been taken as needed.

But now, the new low-dose formulation of Cialis is taken continually, eliminating the need to plan sex within a limited time frame. Lilly plans to start launching the once-daily version in certain European countries in the second half of this year.

C
ialis is one of Lilly's fastest-growing drugs. Its worldwide sales rose 19 percent in Lilly's first quarter, to $266 million.

Source: XMLFULL/XMLFull2729.xml
ADVERTISEMENT

Recent Articles by IBJ Staff

Comments powered by Disqus